The pursuit of outperformance leads many investors to carefully choose individual stocks. Picking the right ones can be a game-changer for growing your wealth.
After finishing at $0.23 in the prior trading day, Adial Pharmaceuticals Inc (NASDAQ: ADIL) closed at $0.22, down -3.76%. In other words, the price has decreased by -$3.76 from its previous closing price. On the day, 0.33 million shares were traded. ADIL stock price reached its highest trading level at $0.2387 during the session, while it also had its lowest trading level at $0.2165.
Ratios:
Our goal is to gain a better understanding of ADIL by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 4.34 and its Current Ratio is at 4.34. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
. In the most recent recommendation for this company, Rodman & Renshaw on November 14, 2024, initiated with a Buy rating and assigned the stock a target price of $8. On October 30, 2018, Maxim Group started tracking the stock assigning a Buy rating and target price of $5.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ADIL now has a Market Capitalization of 5862909 and an Enterprise Value of 670980.
Stock Price History:
The Beta on a monthly basis for ADIL is 1.18, which has changed by -0.7830189 over the last 52 weeks, in comparison to a change of 0.17511821 over the same period for the S&P500. Over the past 52 weeks, ADIL has reached a high of $1.30, while it has fallen to a 52-week low of $0.22. The 50-Day Moving Average of the stock is -28.30%, while the 200-Day Moving Average is calculated to be -51.17%.
Shares Statistics:
The stock has traded on average 482.42K shares per day over the past 3-months and 381450 shares per day over the last 10 days, according to various share statistics. A total of 26.65M shares are outstanding, with a floating share count of 25.99M. Insiders hold about 2.47% of the company’s shares, while institutions hold 2.28% stake in the company. Shares short for ADIL as of 1765756800 were 407422 with a Short Ratio of 0.84, compared to 1763078400 on 419384. Therefore, it implies a Short% of Shares Outstanding of 407422 and a Short% of Float of 1.53.
Earnings Estimates
Adial Pharmaceuticals Inc (ADIL) is currently under the scrutiny of 3.0 analysts, each contributing to the ongoing evaluation of its stock.The consensus estimate for the next quarter is -$0.1, with high estimates of -$0.06 and low estimates of -$0.14. Analysts are recommending an EPS of between -$0.48 and -$0.52 for the fiscal current year, implying an average EPS of -$0.5. EPS for the following year is -$0.38, with 2.0 analysts recommending between -$0.26 and -$0.51.
